Nautilus Biotechnology In...

0.84
-0.02 (-2.44%)
At close: Apr 01, 2025, 3:59 PM
0.87
4.23%
After-hours: Apr 01, 2025, 06:22 PM EDT

Nautilus Biotechnology Income Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue n/a 5.71M 3.42M 2.84M 2.35M n/a n/a
Gross Profit n/a -5.71M -3.42M -2.84M -2.35M n/a n/a
Operating Income n/a -76.15M -63.62M -50.5M -15.74M -10.11K -111.68M
Interest Income 10.78M 12.55M 5.82M 329K n/a n/a n/a
Pretax Income -70.78M -63.67M -57.92M -50.31M -15.62M -9.62K 626.6M
Net Income -70.78M -63.67M -63.74M -50.31M -15.62M -9.62K 626.6M
Selling & General & Admin 31M 28.9M 25.95M 21.15M 3.31M 1.62K 111.68M
Research & Development 50.48M 45.4M 37.67M 29.35M 12.43M 8.49K n/a
Other Expenses n/a n/a -122K 183K 125K n/a n/a
Operating Expenses 81.48M 76.15M 63.62M 50.5M 15.74M 9.62K 111.68M
Interest Expense n/a n/a 5.82M n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses n/a 76.15M 63.62M 50.5M 15.74M 9.62K 111.68M
Income Tax -70.78M n/a 5.82M 2.61M 2.14M -171.31K 738.12M
Shares Outstanding (Basic) 125.43M 124.92M 124.59M 84.46M 29.96M 7.19M 7.19M
Shares Outstanding (Diluted) 125.43M 124.92M 124.59M 84.46M 29.96M 7.19M 7.19M
EPS (Basic) -0.56 -0.51 -0.51 -0.6 -0.52 -0.00 87.18
EPS (Diluted) -0.56 -0.51 -0.51 -0.6 -0.52 -0.00 87.18
EBITDA n/a -74.3M -54.51M -47.47M -13.27M -9.56M 626.6M
EBIT n/a -76.15M -63.62M -50.5M -15.74M -10.11M n/a
Depreciation & Amortization n/a 1.85M 3.42M 2.84M 2.35M 548K 738.28M